Cargando…
Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis
The antibody era has greatly impacted cancer management in recent decades. Indeed, antibodies are currently applied for both cancer diagnosis and therapy. For example, monoclonal antibodies are the main constituents of several in vitro diagnostics, which are applied at many levels of cancer diagnosi...
Autores principales: | Duranti, Claudia, Arcangeli, Annarosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640718/ https://www.ncbi.nlm.nih.gov/pubmed/31544839 http://dx.doi.org/10.3390/antib8020033 |
Ejemplares similares
-
New Trends in Cancer Therapy: Targeting Ion Channels and Transporters
por: Arcangeli, Annarosa, et al.
Publicado: (2010) -
A Comment on Ion Channels as Pharmacological Targets in Oncology
por: Becchetti, Andrea, et al.
Publicado: (2008) -
The role of ion channels and transporters in cell proliferation and cancer
por: Becchetti, Andrea, et al.
Publicado: (2013) -
Ion channels as therapeutic antibody targets
por: Hutchings, Catherine J., et al.
Publicado: (2018) -
K(V)11.1 Potassium Channel and the Na(+)/H(+) Antiporter NHE1 Modulate Adhesion-Dependent Intracellular pH in Colorectal Cancer Cells
por: Iorio, Jessica, et al.
Publicado: (2020)